Karl B. Wagner is CFO at PEDIATRIX MEDICAL GROUP INC (PDX). They have made 9 open-market trades across 1 company since 2006, most recently 2016-06-07.
CIK 0001218840
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MD | SELL | 2016-06-07 | 2016-06-08 | $68.45 | $3.8M | +0.4% | +8.4% | -4.6% |
| MD | SELL · 10b5-1 | 2015-06-08 | 2015-06-10 | $70.28 | $2.7M | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2014-10-30 | 2014-10-31 | $62.50 | $2.5M | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2014-07-30 | 2014-08-01 | $60.00 | $4.8M | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2014-06-06 | 2014-06-06 | $58.53 | $2.6M | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2014-05-09 | 2014-05-09 | $57.10 | $4.5M | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2013-11-07 | 2013-11-08 | $107.60 | $194K | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2013-08-07 | 2013-08-09 | $98.01 | $2.5M | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2012-11-29 | 2012-11-30 | $78.90 | $2.0M | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2011-11-08 | 2011-11-10 | $69.72 | $1.7M | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2011-05-04 | 2011-05-05 | $72.02 | $2.1M | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2009-09-02 | 2009-09-04 | $52.02 | $723K | -6.0% | +0.7% | +0.7% |
| MD | SELL | 2009-05-29 | 2009-06-02 | $40.52 | $182K | -6.0% | +0.7% | +0.7% |
| PDX | SELL · 10b5-1 | 2007-08-31 | 2007-09-05 | $59.72 | $700K | +3.8% | +1.0% | +1.0% |
| PDX | SELL · 10b5-1 | 2007-08-08 | 2007-08-10 | $56.59 | $2.1M | +3.8% | +1.0% | +1.0% |
| PDX | SELL · 10b5-1 | 2006-02-08 | 2006-02-10 | $92.18 | $3.5M | +3.8% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.